[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Viz.ai, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":68},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100602038","copd-exacerbation-follow-up-100602038",false,"NCT07118306","COPD Exacerbation Follow Up","A Multicenter Study of the Impact of a COPD Identification and Referral System on Patient Follow Up and Outcomes After an Acute COPD Exacerbation Resulting in an Emergency Department Visit or Hospitalization","Inclusion Criteria:\n\n* Patients aged 40 years or older at the time of arrival to the emergency department.\n* Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.\n* A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and\u002For antibiotics.\n* A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for \\>24 hours in emergency department\u002Furgent care facility or resulting in death.\n* Patients on dual (LABA\u002FLAMA, LABA\u002FICS, LAMA\u002FICS) or triple (LABA\u002FLAMA\u002FICS) long-acting bronchodilator inhalers.\n\nExclusion Criteria:\n\n* Patients on bronchodilator inhaler monotherapy.\n* Patients leaving against medical advice or expiring during hospitalization.\n* Patients with tracheostomy.\n* Patients with advanced cancer.\n* Patients who have received a lung transplant.\n* Discharge to hospice care.\n* Transfer to another hospital.","ALL","40 Years",{"count":19,"type":20},485,"ESTIMATED","OBSERVATIONAL","The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.",[24],"COPD (Chronic Obstructive Pulmonary Disease)",[26,27,28,29],"COPD","Chronic obstructive pulmonary disease","Exacerbation","VizCOPD","RECRUITING","2026-06-02",{"date":33,"type":34},"2026-06-03","ACTUAL",{"date":36,"type":34},"2026-02-27",{"date":38,"type":20},"2027-12",{"name":40,"class":41},"Viz.ai, Inc.","INDUSTRY",4,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},"100600866","viz-access-hcm---multi-site-registry-100600866","NCT07103057","VIZ ACCESS HCM - Multi-Site Registry","ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry","All Cohorts\n\n* Patients aged 18+ years at time of arrival to healthcare facility\n* Patients with a resting 12-lead digital electrocardiogram (ECG) that is flagged by Viz HCM for HCM suspicion\n\nAdditional cohort-specific criteria:\n\nCohort 1 - Newly Diagnosed Patients\n\n* Patients have been diagnosed with HCM after the Viz HCM implementation\n* Written informed consent is obtained prior to data collection\n\nCohort 2 - Previously Diagnosed Patients ● Prior diagnosis of HCM as evidenced by clinical diagnosis documentation prior to Viz HCM implementation\n\nCohort 3 - Suspected and Not Diagnosed Patients\n\n● Patients did not receive sufficient clinical workup for HCM diagnosis confirmation\n\nCohort 4 - Unlikely HCM ● Patient ECG moved to 'Unlikely HCM' group within Viz by site study staff following HCM alert review\n\nCohort 5 - Alerts Not Reviewed\n\n● HCM alert not reviewed by site study staff during study enrollment period","18 Years",{"count":52,"type":20},500,"To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.",[55],"Hypertrophic Cardiomyopathy",[57,58],"Artificial Intelligence","HCM","2025-08-12",{"date":61,"type":34},"2025-08-17",{"date":63,"type":34},"2025-06-13",{"date":65,"type":20},"2028-12",{"name":40,"class":41},3,""]